| RS794726841 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726842 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726843 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726844 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726845 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726846 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726847 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726848 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726849 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726850 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726851 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726852 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726853 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726854 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726855 |
TUBGCP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly and chorioretinopathy 3, Microcephaly and chorioretinopathy 3 |
| RS794726856 |
TUBGCP4
|
Health Risk |
Pathogenic |
Microcephaly and chorioretinopathy 3, Microcephaly and chorioretinopathy 3 |
| RS794726857 |
MT-ATP6
|
Health Risk |
Likely pathogenic |
Myopathy, lactic acidosis |
| RS794726858 |
CNNM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomagnesemia, seizures |
| RS794726859 |
SLC6A1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy, Epilepsy with myoclonic atonic seizures |
| RS794726860 |
SLC6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Epilepsy with myoclonic atonic seizures |
| RS794726861 |
RBP4
|
Health Risk |
Likely pathogenic |
Microphthalmia, isolated |
| RS794726862 |
RBP4
|
Health Risk |
Pathogenic |
Microphthalmia, isolated |
| RS794726863 |
RNF113A
|
Health Risk |
Likely pathogenic |
Trichothiodystrophy 5, nonphotosensitive |
| RS794726864 |
PDE3A
|
Health Risk |
Pathogenic |
Brachydactyly-arterial hypertension syndrome, Brachydactyly-arterial hypertension syndrome |
| RS794726865 |
PDE3A
|
Health Risk |
Pathogenic |
Brachydactyly-arterial hypertension syndrome, Brachydactyly-arterial hypertension syndrome |
| RS794726866 |
PDE3A
|
Health Risk |
Pathogenic |
Brachydactyly-arterial hypertension syndrome, Inborn genetic diseases |
| RS794726867 |
PDE3A
|
Health Risk |
Pathogenic |
Brachydactyly-arterial hypertension syndrome, Brachydactyly-arterial hypertension syndrome |
| RS794726868 |
PDE3A
|
Health Risk |
Pathogenic |
Brachydactyly-arterial hypertension syndrome, Brachydactyly-arterial hypertension syndrome |
| RS794726869 |
MARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 25, Combined oxidative phosphorylation defect type 25 |
| RS794726871 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS794726872 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, CDKN1C-related disorder |
| RS794726873 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS794726876 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS794726877 |
IDUA
|
Health Risk |
Pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS794726878 |
IDUA
|
Health Risk |
Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS794726880 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS794726882 |
PEX7
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 9B, PEX7-related disorder |
| RS794726886 |
GLB1
|
Health Risk |
Likely pathogenic |
— |
| RS794726887 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS794726890 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS794726893 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS794726896 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS794726897 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS794726898 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS794726906 |
SPG7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 7, SPG7-related disorder |
| RS794726910 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS794726912 |
RECQL4
|
Health Risk |
Pathogenic |
— |
| RS794726921 |
LMNA
|
Health Risk |
Pathogenic |
— |
| RS794726924 |
SOX3
|
Health Risk |
Conflicting classifications of pathogenicity |
SOX3-related disorder, SOX3-related disorder |
| RS794726927 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS794726932 |
SLC16A2
|
Health Risk |
Pathogenic |
— |
| RS794726933 |
SLC16A2
|
Health Risk |
Likely pathogenic |
— |
| RS794726937 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS794726941 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
MAGEL2-related disorder, MAGEL2-related disorder |
| RS794726942 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS794726944 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS794726945 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS794726950 |
COG6
|
Health Risk |
Pathogenic |
— |
| RS794726951 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS794726954 |
CDHR1
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 15, Retinitis pigmentosa |
| RS794726956 |
CHST14
|
Health Risk |
Pathogenic |
— |
| RS794726957 |
SYN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, X-linked 1 |
| RS794726959 |
ARX
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS794726964 |
NHLRC1
|
Health Risk |
Pathogenic |
— |
| RS794726967 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS794726968 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS794726969 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS794726971 |
GALT
|
Health Risk |
Pathogenic |
— |
| RS794726972 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS794726973 |
GUSB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS794726974 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS794726975 |
NPHP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis 1 |
| RS794726976 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS794726979 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS794726983 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS794726987 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Familial thoracic aortic aneurysm and aortic dissection |
| RS794726989 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory and autonomic |
| RS794726991 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 15, Retinitis pigmentosa 14 |
| RS794726993 |
DMD
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 3B, Duchenne muscular dystrophy |
| RS794726994 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS794726996 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS794727001 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS794727003 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS794727006 |
BBS1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Bardet-Biedl syndrome |
| RS794727012 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS794727014 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS794727016 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS794727017 |
IDUA
|
Health Risk |
Likely pathogenic |
— |
| RS794727019 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Retinitis pigmentosa 3 |
| RS794727025 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS794727026 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS794727028 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS794727029 |
VRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Pontocerebellar hypoplasia type 1A |
| RS794727030 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS794727031 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS794727032 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS794727035 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS794727037 |
PKHD1
|
Health Risk |
Pathogenic |
— |
| RS794727040 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS794727043 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |